GlassScriptPhysician profile
Priya S Shetty
NPI 1760680649
$6,473.96
in general payments reported to CMS, 2019-2025
22 companies · $1,590 in 2025
The $1,590 reported for 2025 was more than what 85% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $357 · 2020: $375 · 2021: $872 · 2022: $832 · 2023: $1,243 · 2024: $1,205 · 2025: $1,590.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,037.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,037.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $3,028.62 | 2019-2025 | Hydrus Microstent, Clareon Panoptix Pro, Clareon |
| Abbvie INC. | $1,072.84 | 2022-2025 | Durysta, Ozurdex, Lumigan |
| Allergan, INC. | $464.64 | 2020-2022 | |
| Glaukos Corporation | $411.42 | 2019-2023 | Istent Infinite Trabecular Micro-Bypass System Model Is3, Is3-Istent Infinitetrabecular Micro-Bypass System Model Is3 |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $340.76 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $333.08 | 2022-2024 | Envista Mx60 Iol, Miebo, Xiidra |
| Tarsus Pharmaceuticals, INC. | $133.14 | 2024-2025 | Xdemvy |
| Harrow Eye, LLC | $111.98 | 2023-2025 | Iheezo, Vevye |
| Genentech USA, INC. | $84.59 | 2023-2025 | Vabysmo |
| Astellas Pharma US INC | $67.52 | 2023-2025 | Izervay |
| Johnson & Johnson Surgical Vision, INC. | $66.87 | 2025 | Tecnis Iol, Tecnis Simplicity, Tecnis Iol |
| Biogen, INC. | $66.74 | 2022-2024 | Byooviz |
| Regeneron Healthcare Solutions, INC. | $63.06 | 2022-2024 | Eylea Hd |
| Thea Pharma INC. | $58.68 | 2022-2024 | Iyuzeh |
| Sun Pharmaceutical Industries INC. | $34.26 | 2023-2024 | Cequa |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lumenis, INC | $26.31 | 2021 | |
| New World Medical,INC. | $21.33 | 2023-2025 | Via360, Streamline, Ahmed Glaucoma Valve |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Apellis Pharmaceuticals, INC. | $18.28 | 2023 | |
| Biotissue Holdings INC. | $17.83 | 2024 | |
| Amgen INC. | $17.75 | 2025 | Tepezza |
| Carl Zeiss Meditec USA, INC. | $14.86 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Priya Shetty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.